accur
diagnosi
viral
infect
enhanc
abil
clinician
make
decis
appropri
treatment
patient
evalu
diseas
progress
prevent
misus
antibiot
knowledg
pathogen
involv
also
allow
implement
infect
control
monitor
success
antivir
treatment
may
affect
prognosi
patient
epidemiolog
data
collect
accur
diagnost
play
import
role
public
health
identif
control
outbreak
implement
appropri
diagnost
test
vaccin
program
treatment
also
recogn
common
emerg
pathogen
commun
key
clinician
understand
appropri
specimen
send
laboratori
valu
specif
nucleic
acid
serolog
test
differ
viral
pathogen
molecular
techniqu
revolution
viral
diagnos
past
decad
enhanc
sensit
specif
test
speed
diagnosi
made
new
test
develop
continu
use
serolog
virus
short
viremia
chronic
infect
howev
complement
test
chapter
aim
provid
overview
avail
test
principl
test
appropri
test
select
differ
virus
syndrom
also
provid
glimps
new
develop
diagnost
may
enhanc
capac
make
conclus
diagnosi
near
futur
human
viru
infect
may
affect
age
may
impact
morbid
mortal
acut
chronic
recurr
lifelong
infect
may
depend
immun
statu
patient
abil
clear
viru
infect
well
characterist
pathogen
develop
sensit
specif
method
detect
viral
nucleic
acid
antivir
antibodi
greatli
advanc
abil
make
accur
diagnos
differ
stage
diseas
previous
extend
period
need
identif
viral
etiolog
greatli
depend
upon
viru
isol
techniqu
meant
viral
diagnos
epidemiolog
valu
advanc
made
diagnost
techniqu
past
decad
significantli
improv
accuraci
timeli
viral
diagnosi
turn
aid
patient
manag
diseas
control
posit
impact
diseas
outcom
sinc
develop
antivir
drug
treatment
option
avail
viral
infect
clinician
encourag
seek
viral
laboratori
diagnosi
provid
clinic
use
inform
diagnosi
manag
patient
requir
focu
laboratori
shift
provid
better
faster
diagnosi
driven
develop
new
approach
monitor
viral
infect
support
antivir
treatment
quantit
viral
load
antivir
suscept
test
viral
genotyp
pointofcar
test
despit
massiv
impact
molecular
diagnost
viral
diagnosi
signific
stride
made
antigen
detect
serolog
test
develop
rapid
test
direct
detect
viral
antigen
clinic
specimen
detect
antibodi
convalesc
chronic
infect
laboratori
control
molecular
serolog
test
continu
advantag
superior
sensit
specif
differenti
diagnost
option
control
environ
increas
sensit
specif
divers
virolog
diagnost
assay
avail
clinician
work
collabor
virolog
laboratori
maxim
diagnost
potenti
appropri
clinic
specimen
understand
relev
diagnost
test
request
specif
virus
differ
age
interpret
posit
test
remain
key
clinic
manag
patient
aim
chapter
provid
overview
diagnost
methodolog
avail
viral
diagnosi
rather
extens
technic
detail
assay
aim
provid
overview
option
avail
clinician
common
assay
recent
develop
rational
use
could
success
employ
better
clinic
manag
patient
import
factor
influenc
accuraci
viral
diagnost
result
specimen
whichev
method
use
laboratori
result
larg
depend
upon
right
specimen
type
taken
right
time
store
transport
correctli
understand
pathogenesi
epidemiolog
viru
involv
help
identifi
correct
test
specimen
type
collect
acut
virus
crucial
take
time
sinc
infect
consider
whether
viru
circul
commonli
popul
caus
reinfect
figur
depict
typic
period
acut
virus
detect
blood
time
igm
becom
visibl
later
igg
mani
acut
virus
viremia
vari
may
rel
short
viru
detect
first
day
time
clinic
symptom
becam
appar
either
blood
urin
caus
system
infect
arbovirus
measl
stool
enter
virus
rotaviru
polioviru
site
infect
respiratori
tract
respiratori
virus
central
nervou
system
neuroinvas
infect
time
viru
specif
test
viru
isol
antigen
test
molecular
test
revers
transcript
rt
polymeras
chain
reaction
pcr
appropri
virus
less
common
environ
arbovirus
childhood
diseas
prior
vaccin
igm
antibodi
test
request
day
may
detect
earli
specimen
appropri
common
virus
respiratori
virus
may
caus
frequent
reinfect
igg
antibodi
would
use
diagnos
acut
infect
pair
serum
avail
day
apart
use
common
virus
may
caus
frequent
reinfect
igg
test
may
also
use
determin
immun
statu
follow
vaccin
matern
antibodi
interfer
igg
test
first
month
life
therefor
chronic
diseas
hiv
transmiss
children
hivinfect
mother
dna
pcr
test
suitabl
specimen
use
viru
isol
rtpcr
kept
reach
laboratori
within
hour
keep
rna
intact
envelop
singl
strand
rna
virus
rsv
success
rate
declin
hour
effort
made
keep
specimen
ice
time
collect
reach
laboratori
blood
usual
requir
volum
ml
depend
patient
age
appropri
tube
determin
test
requir
appropri
blood
compon
test
whole
blood
plasma
serum
anticoagul
heparin
may
inhibit
pcr
edta
tube
prefer
molecular
test
serolog
clot
blood
may
collect
sst
serum
separ
tube
tube
allow
separ
red
blood
cell
serum
centrifug
viru
isol
may
prefer
whole
blood
edta
serum
clot
blood
depend
viru
swab
swab
dacron
rayon
tip
prefer
ensur
cell
collect
place
viral
transport
medium
preserv
labil
virus
viral
isol
rtpcr
wash
aspir
nasopharyng
aspir
fluid
saliva
urin
place
viral
transport
medium
although
csf
usual
prefer
undilut
stool
obtain
least
g
stool
place
steril
contain
tissu
place
steril
contain
small
amount
viral
transport
medium
viral
diagnosi
specimen
clot
blood
must
kept
transport
ice
retain
viabil
virus
keep
nucleic
acid
intact
tabl
summar
type
specimen
relev
test
avail
virus
associ
differ
syndrom
may
affect
children
adult
method
use
diagnost
virolog
although
one
oldest
techniqu
routin
use
diagnost
laboratori
anymor
electron
microscopi
em
method
avail
directli
visual
viru
therefor
mani
applic
beyond
pure
diagnost
visual
virus
em
involv
neg
stain
clinic
specimen
neg
stain
clinic
sampl
rel
straightforward
inexpens
techniqu
would
repres
catch
method
viral
identif
em
could
particularli
use
identifi
fastidi
noncultiv
viru
specimen
provid
high
viru
concentr
sensit
limit
approxim
viral
particl
per
millilit
specimen
make
neg
result
difficult
interpret
sensit
could
increas
ultracentrifug
antibodyinduc
clump
limit
lack
specif
em
identifi
famili
level
whereaft
method
would
appli
specif
diagnosi
although
major
advantag
em
speed
result
could
obtain
min
high
cost
instrument
special
train
expert
need
coupl
lack
sensit
specif
make
viabl
option
routin
diagnost
direct
microscopi
stain
histolog
cytolog
specimen
may
instanc
give
first
indic
viral
involv
involv
cellular
chang
virus
cmv
vzv
hpv
bk
specif
cytolog
chang
confirm
stain
specif
antigen
genom
sequenc
use
antibodi
nucleic
acid
probe
specif
pcr
amplif
techniqu
may
outperform
techniqu
sensit
although
detect
antigen
tissu
highli
specif
viral
tissu
cultur
tradit
gold
standard
use
diagnos
viru
infect
howev
last
year
molecular
techniqu
becom
routin
viru
isol
need
remain
import
part
viral
diagnost
order
maintain
sourc
analyz
genotyp
chang
also
phenotyp
chang
viru
popul
vaccin
relev
epidemiolog
allow
identif
chang
antigen
pathogen
viral
characterist
updat
vaccin
influenza
vaccin
match
circul
strain
qualiti
specimen
time
take
reach
laboratori
transport
cold
chain
determin
success
viru
isol
detect
virus
cell
cultur
requir
consider
expertis
perform
microscop
examin
look
degen
morpholog
chang
cell
monolay
call
cytopath
effect
cpe
virus
grow
cell
type
produc
cpe
antigen
nucleic
detect
method
requir
correctli
identifi
specif
viru
involv
clinic
specimen
usual
inocul
onto
sever
cell
line
provid
optimum
environ
rang
virus
tabl
adapt
tradit
viral
cultur
format
develop
allow
rapid
detect
virus
especi
virus
known
grow
slowli
convent
cell
cultur
achiev
inocul
specimen
onto
microscop
slide
centrifug
cultur
enhanc
infect
rate
shell
vial
assay
enhanc
detect
rate
may
result
better
contact
cell
specimen
cell
cultur
thu
allow
earlier
extens
infect
cell
line
well
use
fluorescentlabel
eg
fitc
monoclon
antibodi
direct
viral
antigen
nevertheless
cultur
method
lack
sensit
specif
rel
pcr
remain
howev
catchal
method
choic
viru
question
cultur
virus
detect
directli
clinic
sampl
use
highli
specif
nucleic
acid
primer
probe
complementari
sequenc
rna
virus
use
rtpcr
dna
virus
directli
pcr
past
year
nucleic
acid
amplif
test
develop
major
virus
public
health
concern
becom
new
benchmark
viral
diagnos
publish
sensit
specif
usual
nearli
compar
cell
cultur
antigen
assay
fact
studi
compar
molecular
assay
tissu
cultur
assay
demonstr
significantli
increas
sensit
develop
realtim
pcr
incorpor
use
specif
floresc
label
probe
creat
abil
monitor
dna
amplif
process
happen
realtim
dedic
instrument
capabl
collect
fluoresc
data
everi
pcr
cycl
accumul
measur
fluoresc
end
everi
pcr
cycl
plot
display
sigmoid
curv
data
analyz
cycl
threshold
ct
valu
assign
target
amplif
first
detect
ct
point
amplicon
fluoresc
exce
background
indirectli
proportion
initi
concentr
target
dna
sampl
ie
higher
concentr
initi
sampl
lower
ct
valu
compar
studi
reveal
detect
respiratori
virus
use
realtim
revers
transcriptas
polymeras
chain
reaction
rrtpcr
assay
substanti
sensit
use
convent
method
viral
cultur
furthermor
compar
convent
pcr
realtim
method
multiplex
rrtpcr
advantag
permit
simultan
amplif
sever
virus
singl
reaction
facilit
costeffect
diagnosi
enabl
detect
multipl
virus
singl
clinic
specimen
amplif
sever
virus
togeth
may
howev
sacrific
sensit
individu
assay
much
effort
gone
identifi
way
increas
sensit
multiplex
pcr
assay
frequent
use
detect
presenc
rang
virus
involv
specif
syndrom
respiratori
infect
e
adenovirus
adv
disadvantag
includ
higher
startup
cost
higher
reagent
cost
extens
specif
train
specialist
laboratori
special
equip
run
divers
fastidi
natur
short
viremia
period
pathogen
may
caus
infect
lack
avail
diagnost
test
sever
hamper
abil
identifi
etiolog
differ
clinic
syndrom
sever
multiplex
platform
develop
either
set
duplex
assay
inhous
commerci
multiplex
system
requir
special
equip
read
avail
rang
syndrom
limit
factor
sensit
assay
requir
pcr
amplif
detect
product
number
platform
includ
masstag
pcr
microarray
platform
macro
array
microbead
base
method
taqman
array
card
current
taqman
array
card
increas
popular
due
eas
adapt
specif
purpos
assay
applic
diagnosi
singl
case
part
epidemiolog
studi
describ
etiolog
specif
syndrom
taqman
array
card
tac
life
technolog
foster
citi
ca
usa
assay
develop
use
success
sever
syndrom
respiratori
diseas
enter
diseas
neonat
sepsi
develop
taqman
array
card
stabl
year
ship
ambient
temperatur
tac
assay
microfluid
array
consist
ident
array
eight
individu
microfluid
channel
load
nucleic
acid
extract
clinic
specimen
posit
control
individu
channel
consist
well
contain
singleplex
qpcr
reaction
target
differ
pathogen
thu
eight
specimen
assay
per
tac
card
simultan
detect
pathogen
per
specimen
make
tac
assay
popular
follow
reason
minim
specimen
volum
requir
reduct
cross
contamin
specimen
due
close
system
format
abil
tailor
panel
pathogen
detect
requir
proven
efficaci
technolog
pathogen
detect
similar
studi
simpl
use
format
multiplex
method
becom
common
routin
diagnost
laboratori
howev
larg
scale
method
describ
predominantli
research
base
use
epidemiolog
studi
specialist
laboratori
rather
routin
next
gener
sequenc
method
make
use
deep
sequenc
nucleic
acid
present
sampl
current
mostli
use
pathogen
discoveri
specialist
laboratori
detect
outbreak
gener
amplif
step
still
need
use
clinic
specimen
addit
techniqu
expens
run
larg
scale
routin
diagnost
laboratori
even
though
techniqu
becom
afford
gener
signific
amount
data
requir
train
bioinformatician
interpret
output
larg
comput
system
nevertheless
develop
autom
system
identifi
virus
directli
clinic
specimen
may
futur
make
techniqu
access
routin
diagnost
increas
sensit
develop
molecular
assay
highlight
advantag
identifi
new
virus
associ
diseas
respiratori
virus
describ
last
decad
includ
hmpv
hcov
also
reveal
flaw
make
interpret
posit
pcr
result
problemat
recent
literatur
shown
specif
case
rv
viru
detect
asymptomat
well
symptomat
patient
due
increas
sensit
molecular
assay
possibl
detect
presenc
viru
low
genom
copi
number
may
repres
preor
postsyndrom
phase
viral
infect
redefin
natur
viral
diseas
clinic
interpret
thereof
interpret
qualit
quantit
pcr
result
well
applic
appropri
choic
would
requir
close
liaison
virolog
laboratori
qualit
detect
specimen
normal
viru
free
good
exampl
diagnosi
viral
asept
enceph
test
csf
hsv
cmv
vzv
enterovirus
diagnost
qualit
pcr
offer
signific
advantag
term
speed
especi
develop
pointofcar
test
earli
diagnosi
treatment
cn
infect
proven
improv
prognosi
reduc
unnecessari
treatment
hospit
virus
exhibit
lowlevel
viru
shed
absenc
symptom
viral
gastroenter
caus
rotaviru
noroviru
could
detect
stool
sampl
assay
quantifi
amount
viru
infect
patient
proven
valuabl
tool
manag
chronic
viral
infect
mani
persist
viral
infect
transient
lowlevel
viremia
onset
symptom
associ
spike
viral
replic
thu
higher
viral
load
allow
predict
diseas
onset
allow
better
clinic
manag
patient
clinician
monitor
progress
diseas
success
treatment
emerg
drug
resist
understand
pathogenesi
particular
viru
cmv
ebv
hbv
hcv
avail
antivir
drug
increas
emphasi
place
assay
determin
caus
treatment
failur
antivir
resist
one
possibl
outcom
emerg
antivir
resist
document
virtual
antivir
compound
specif
viral
mutat
associ
resist
becom
better
understood
laboratori
assay
determin
drug
resist
fall
two
major
categori
phenotyp
assay
phenotyp
assay
larg
replac
molecular
base
genotyp
assay
howev
remain
gold
standard
determin
drug
efficaci
suscept
concentr
drug
requir
inhibit
viral
replic
calcul
hiv
best
exampl
phenotyp
assay
ad
advantag
give
complet
overview
mutat
observ
howev
expens
labori
techniqu
success
greatli
depend
level
train
staff
whether
specif
viru
cultureadapt
strain
avail
genotyp
assay
develop
rtpcr
genotyp
assay
focus
specif
area
viru
genom
ad
advantag
rapid
rel
inexpens
semiquantit
singl
point
mutat
assay
allel
discrimin
assay
difficult
interpret
singl
point
mutat
without
requir
inform
phenotyp
assay
would
provid
develop
new
autom
sequenc
method
enabl
studi
genet
basi
drug
resist
made
assess
viru
isol
reduc
drug
suscept
access
use
sequenc
base
method
test
antivir
resist
also
becom
routin
viral
diagnost
especi
hiv
hbv
biggest
drawback
techniqu
expens
downstream
analysi
sequenc
data
gener
sequenc
edit
interpret
requir
case
hiv
identif
resist
depend
upon
recognit
specif
sequenc
pattern
softwar
system
use
serolog
techniqu
either
target
antigen
acut
phase
infect
viru
specif
antibodi
later
infect
viru
specif
antigen
may
detect
first
day
acut
infect
igm
antibodi
detect
within
day
follow
infect
may
remain
month
patient
blood
infect
clear
therefor
igm
use
detect
recent
infect
igg
antibodi
detect
day
infect
present
life
seroconvers
igg
measur
pair
sera
taken
acut
convalesc
phase
day
apart
signific
rise
antibodi
fourfold
increas
seen
posit
reaction
new
infect
singl
igg
posit
test
may
reflect
infect
time
past
pediatr
infect
matern
immun
need
taken
consider
first
month
life
may
clear
month
may
therefor
interfer
serolog
diagnosi
infant
assay
detect
igm
igg
usual
qualit
sinc
presenc
absenc
antibodi
enough
make
diagnosi
howev
rise
antibodi
detect
test
need
quantit
order
detect
increas
antibodi
first
second
specimen
antibodi
titr
measur
reciproc
highest
serum
dilut
posit
reaction
still
detect
exampl
titr
indic
posit
antibodi
bind
could
detect
serum
dilut
beyond
serolog
techniqu
easili
autom
play
import
part
routin
diagnost
laboratori
import
role
diagnos
acut
chronic
infect
use
develop
rapid
test
addit
complement
molecular
techniqu
clinic
relev
assay
allow
rapid
detect
antigen
appli
directli
clinic
sampl
nasopharyng
aspir
tissu
cultur
tissu
biopsi
specimen
brain
tissu
rabi
viru
ifa
quick
conveni
individu
specimen
requir
skill
oper
easi
scale
sensit
molecular
techniqu
viral
detect
howev
rel
cheap
popular
choic
reason
identif
viral
infect
direct
ifa
detect
viru
infect
specimen
tissu
use
commerci
avail
antibodi
label
floresc
marker
indirect
ifa
detect
antibodi
patient
sera
bind
antigen
viru
infect
tissu
cultur
cell
secondari
antihuman
igg
igm
antibodi
use
detect
patient
bound
antibodi
direct
ifa
frequent
use
respiratori
viru
antigen
detect
respiratori
secret
rsv
influenza
indirect
ifa
igg
igm
antibodi
detect
use
detect
infect
ebv
vzv
amongst
other
elisa
commonli
use
antibodi
antigen
detect
assay
sinc
high
throughput
rapid
easili
autom
object
sinc
output
read
use
spectrophotomet
elisa
work
principl
detect
antibodi
patient
sera
reaction
antigen
bound
surfac
microtitr
plate
patient
serum
ad
bind
antigen
bound
antibodi
detect
addit
secondari
antihuman
antibodi
coupl
enzym
addit
substrat
enzym
link
antigen
antibodi
complex
result
colour
chang
induc
posit
reaction
assay
adjust
igg
igm
addit
antihuman
antibodi
antigen
detect
elisa
perform
coat
solid
phase
antibodi
detect
antigen
patient
sera
order
reveal
detect
antibodi
complex
elisa
frequent
use
detect
igg
igm
antibodi
rubella
measl
mump
hiv
hepat
arbovirus
west
nile
viru
zika
viru
dengu
jev
although
elisa
high
sensit
specif
viral
famili
may
cross
react
exact
identif
virus
flavivirus
neutral
assay
need
confirm
viru
neutral
assay
highli
specif
assay
test
neutral
antibodi
also
use
confirm
result
serolog
assay
elisa
known
crossreact
differ
virus
famili
eg
flavivirus
zika
viru
dengu
west
nile
viru
also
use
determin
vaccin
would
provid
protect
eg
detect
antigen
drift
neutral
epitop
annual
influenza
vaccin
antigen
mix
dilut
antibodi
inhibit
cpe
observ
inocul
tissu
monolay
inhibit
effect
either
read
observ
cpe
overlay
agar
allow
plaqu
format
plaqu
reduct
neutral
assay
prnt
microneutr
assay
also
read
elisa
method
help
autom
process
reduc
test
run
time
infect
cell
detect
techniqu
labour
intens
routin
done
diagnost
laboratori
rather
refer
specialist
laboratori
sever
format
serolog
techniqu
exist
use
differ
purpos
hemagglutin
inhibit
assay
hai
test
detect
antibodi
virus
hemagglutinin
antigen
includ
rubella
influenza
flavivirus
test
still
routin
use
refer
laboratori
identifi
especi
cross
reactiv
virus
flavivirus
confirm
specif
virus
neutral
assay
investig
influenza
antigen
variat
rel
sera
rais
vaccin
due
cross
reactiv
requir
fresh
red
blood
cell
less
commonli
employ
routin
laboratori
western
blot
techniqu
still
use
confirm
hiv
hcv
base
principl
transfer
specif
viral
protein
separ
gel
blot
paper
follow
bind
patient
serum
detect
antihuman
enzym
label
antibodi
substrat
specif
sensit
may
vari
antigen
detect
method
allow
develop
rapid
antigen
antibodi
test
allow
bedsid
diagnosi
howev
variabl
sensit
specif
determin
valu
test
follow
trend
molecular
diagnost
develop
multiplex
serolog
assay
cover
rang
viral
antigen
associ
specif
syndrom
significantli
improv
diagnost
capac
laboratori
method
use
multiplex
microspherebas
suspens
immuno
assay
sia
simultan
detect
igg
antibodi
rang
virus
enabl
develop
syndrom
applic
specif
test
exampl
would
cmv
gondii
combin
sia
multiplex
rapid
antibodi
screen
pregnanc
assay
bind
number
antigen
antibodi
microspher
incub
patient
sera
visual
label
antihuman
igm
antibodi
similar
test
describ
arboviru
screen
northern
hemispher
multiplex
format
base
protein
array
also
develop
detect
rang
virus
assay
antigen
fix
solid
phase
microchip
slide
test
patient
antiserum
fluoresc
label
antihuman
antibodi
use
detect
posit
chip
identifi
pathogen
involv
array
may
base
peptid
synthes
pathogen
sequenc
recombin
protein
inactiv
viru
antigen
techniqu
yet
wide
avail
routin
diagnost
laboratori
develop
specialist
research
laboratori
howev
autom
possibl
like
improv
access
futur
abil
laboratori
provid
accur
diagnost
result
essenti
effect
clinic
manag
patient
solv
outbreak
respons
decis
make
therefor
monitor
ongo
qualiti
assur
qa
improv
aspect
laboratori
crucial
involv
manag
monitor
servic
process
relat
releas
diagnost
result
process
monitor
relat
preanalyt
phase
ie
specimen
transport
collect
storag
analyt
phase
ie
test
monitor
laboratori
procedur
environ
well
post
analyt
phase
ie
result
report
result
interpret
qa
ensur
annual
assess
staff
compet
calibr
servic
equip
well
qualiti
diagnost
test
clinic
laboratori
strictli
regul
appoint
agenc
audit
accord
specif
standard
set
forth
intern
organ
standard
iso
intern
electrotechn
commiss
iec
primari
qualiti
control
qc
concern
molecular
laboratori
specimen
nucleic
acid
qualiti
integr
assay
sensit
specif
well
fals
posit
test
pcr
contamin
rna
dna
integr
insur
use
rnase
dnase
free
reagent
consum
addit
handl
specimen
ice
pcr
contamin
avoid
physic
organ
laboratori
workflow
separ
work
area
equip
relev
pcr
control
includ
run
ensur
correct
interpret
result
use
uracil
nglycosylas
ung
pcr
reaction
provid
chemic
control
carri
contamin
vital
pcr
diagnost
undertaken
everi
effort
made
minim
contamin
assay
test
laboratori
environ
staff
well
train
compet
type
work
use
accredit
laboratori
ensur
diagnost
find
reliabl
molecular
serolog
techniqu
use
complimentari
fashion
diagnos
viru
infect
knowledg
stage
infect
viral
pathogenesi
epidemiolog
help
make
decis
regard
correct
test
choos
appropri
diagnosi
advanc
specif
sensit
capac
test
rang
virus
multipl
platform
make
accur
diagnosi
rapid
identif
circul
virus
realtim
clinic
relev
data
feasibl
today
viru
isol
collabor
specialist
laboratori
make
newer
techniqu
identif
emerg
reemerg
virus
possibl
qualiti
specimen
patient
clinic
histori
present
close
collabor
clinician
pathologist
laboratori
remain
key
use
diagnost
data
improv
patient
manag
